Cardiomyopathy

Welcome to our featured section on cardiomyopathy

Click here to take the CME-accredited courses. 

This educational hub pulls together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub will be CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos. 

 

See more ▼
Close X
Other videos you might like

Section Advisor

Professor Perry Elliott

Chair, Cardiovascular Medicine, University College London, and Head, Clinical Research, UCL Institute of Cardiovascular Science, London, UK

Supported through an educational grant from Bristol Myers Squibb.

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Video

AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore,

Watch time: 8m 12s
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Video

View from the Thoraxcenter: What's Hot at AHA 2022?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s
HFSA 22: REDWOOD-HCM OLE: KCCQ Scores In Pts With HCM Treated With Aficamten

Video

HFSA 22: KCCQ Scores In Pts With HCM Treated With Aficamten

Sara Saberi,

Watch time: 15m 24s

Broadcast

Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Video Series

e-SPACE CRM 2022

Andrew JS Coats, Stefan Anker,

Video Series

Hypertrophic Cardiomyopathy: Highlights From 2021 & Genetic Testing for HCM

Video Series

e-SPACE Heart Failure 2021

Lars H Lund, James L Januzzi, Justin Ezekowitz, et al

Redwood-HCM: Second-Generation Drug for HCM Well-Tolerated by Patients

Video

Redwood-HCM: Second-Generation Drug for HCM Well-Tolerated by Patients

Martin S Maron,

Recent Videos

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Video

AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 4s
AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Video

AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore,

Watch time: 8m 12s
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Video

View from the Thoraxcenter: What's Hot at AHA 2022?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s
HFSA 22: REDWOOD-HCM OLE: KCCQ Scores In Pts With HCM Treated With Aficamten

Video

HFSA 22: KCCQ Scores In Pts With HCM Treated With Aficamten

Sara Saberi,

Watch time: 15m 24s